Pacific Biosciences of California, Inc. (PACB) vs SL Science Holding Ltd (SLBT)

A side-by-side comparison of Pacific Biosciences of California, Inc. and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Pacific Biosciences of California, Inc. logo
PACB
Pacific Biosciences of California, Inc.
$845M
$2.72HealthcareDelayed quote: Oct 6, 2026, 1:55 PM EDT
SL Science Holding Ltd logo
SLBT
SL Science Holding Ltd
$855M
$1.53HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT

Total return — PACB vs SLBT

growth of $100 · dividends reinvested · last 1y
PACB +156.3% (+156.3%/yr)SLBT -79.6% (-79.6%/yr)PACB compounded faster over this window
Log scale — wide-divergence pair
101001kStart $100$256$20
PACB SLBT

PACB vs SLBT: by the numbers

  • •SLBT is the larger company ($855M vs $845M market cap).
  • •Both run net losses; PACB's is the smaller (-82.49% vs -173.85% net margin).

Metrics side by side

Valuation

MetricPACBSLBT
P/S ratio5.30N/A
P/B ratioN/A374.43

Profitability

MetricPACBSLBT
Gross margin35.97%35.27%
Operating margin-348.46%-174.65%
Net margin-82.49%-173.85%
ROEN/A-167.25%
ROIC-23.80%-163.39%

Growth (annualized)

MetricPACBSLBT
Revenue CAGR (5Y)8.52%N/A
Total return CAGR (5Y)-35.20%N/A

Go deeper

Full PACB analysisFull SLBT analysisInteractive comparison tool

Dig into the metrics

Pacific Biosciences of California ROESL Science ROEPacific Biosciences of California operating marginSL Science operating marginPacific Biosciences of California revenue growthSL Science revenue growthPacific Biosciences of California free cash flowSL Science free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.